Business Context and Reporting Period
Cytosorbents Corp (Nevada) filed a Form 8-K on January 9, 2013, to disclose a shareholder letter summarizing achievements in 2012 and goals for 2013. The filing was signed by Dr. Phillip P. Chan, President and CEO, on January 11, 2013.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a shareholder letter rather than a financial statement.
Material Changes
No material financial changes or comparative period data are detailed within the text of this Form 8-K. The report references a separate shareholder letter (Exhibit 99.1) for details on 2012 achievements.
Guidance, Outlook, and Risks
The Company issued a letter outlining goals for 2013, though specific guidance figures are not included in this filing. The document explicitly states that the information, including the shareholder letter, is furnished and not "filed" for purposes of Section 18 of the Exchange Act, limiting its legal liability and incorporation by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Shareholder letter) for specific 2012 achievements and 2013 goals.
- Verify the Company's financial status through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Confirm the regulatory status of the disclosed information, noting it is not deemed "filed" under Section 18 of the Exchange Act.